Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.894 USD | +9.42% | +5.62% | -19.83% |
Mar. 25 | Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-19.83% | 4.65M | |
+9.16% | 45.97B | |
+53.58% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Finch Therapeutics Group, Inc. - Nasdaq
- News Finch Therapeutics Group, Inc.
- Finch Therapeutics Secures two US Patents for Microbiome Therapeutic Product to Treat Autism Spectrum Disorder